Galvin F - Search Results

1

Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.

Razi-Wolf Z, Galvin F, Gray G, Reiser H. Razi-Wolf Z, et al. Among authors: galvin f. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11182-6. doi: 10.1073/pnas.90.23.11182. Proc Natl Acad Sci U S A. 1993. PMID: 7504299 Free PMC article.

2

Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.

Galvin F, Freeman GJ, Razi-Wolf Z, Hall W Jr, Benacerraf B, Nadler L, Reiser H. Galvin F, et al. J Immunol. 1992 Dec 15;149(12):3802-8. J Immunol. 1992. PMID: 1281187

3

Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells.

Razi-Wolf Z, Freeman GJ, Galvin F, Benacerraf B, Nadler L, Reiser H. Razi-Wolf Z, et al. Among authors: galvin f. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4210-4. doi: 10.1073/pnas.89.9.4210. Proc Natl Acad Sci U S A. 1992. PMID: 1373896 Free PMC article.

4

Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.

Galvin F, Freeman GJ, Razi-Wolf Z, Benacerraf B, Nadler L, Reiser H. Galvin F, et al. Eur J Immunol. 1993 Jan;23(1):283-6. doi: 10.1002/eji.1830230145. Eur J Immunol. 1993. PMID: 7678228

5

The boundary characteristics of lucid dreamers.

Galvin F. Galvin F. Psychiatr J Univ Ott. 1990 Jun;15(2):73-8. Psychiatr J Univ Ott. 1990. PMID: 2374791

6

Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolines.

Knight RL, Allen DR, Birch HL, Chapman GA, Galvin FC, Jopling LA, Lock CJ, Meissner JW, Owen DA, Raphy G, Watson RJ, Williams SC. Knight RL, et al. Among authors: galvin fc. Bioorg Med Chem Lett. 2008 Jan 15;18(2):629-33. doi: 10.1016/j.bmcl.2007.11.075. Epub 2007 Nov 28. Bioorg Med Chem Lett. 2008. PMID: 18068363

7

Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives.

Watson RJ, Allen DR, Birch HL, Chapman GA, Galvin FC, Jopling LA, Knight RL, Meier D, Oliver K, Meissner JW, Owen DA, Thomas EJ, Tremayne N, Williams SC. Watson RJ, et al. Among authors: galvin fc. Bioorg Med Chem Lett. 2008 Jan 1;18(1):147-51. doi: 10.1016/j.bmcl.2007.10.109. Epub 2007 Nov 4. Bioorg Med Chem Lett. 2008. PMID: 18032038

8

Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP.

Davenport RJ, Diaz P, Galvin FC, Lloyd S, Mack SR, Owens R, Sabin V, Wynn J. Davenport RJ, et al. Among authors: galvin fc. Bioorg Med Chem Lett. 2007 Jan 15;17(2):558-61. doi: 10.1016/j.bmcl.2006.10.038. Epub 2006 Oct 19. Bioorg Med Chem Lett. 2007. PMID: 17079144

9

Novel nucleotide triphosphates as potent P2Y2 agonists.

Brookings D, Davenport RJ, Davis J, Galvin FC, Lloyd S, Mack SR, Owens R, Sabin V, Wynn J. Brookings D, et al. Among authors: galvin fc. Bioorg Med Chem Lett. 2007 Jan 15;17(2):562-5. doi: 10.1016/j.bmcl.2006.09.017. Epub 2006 Sep 29. Bioorg Med Chem Lett. 2007. PMID: 17011188

10

Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.

Beevers RE, Buckley GM, Davies N, Fraser JL, Galvin FC, Hannah DR, Haughan AF, Jenkins K, Mack SR, Pitt WR, Ratcliffe AJ, Richard MD, Sabin V, Sharpe A, Williams SC. Beevers RE, et al. Among authors: galvin fc. Bioorg Med Chem Lett. 2006 May 1;16(9):2539-42. doi: 10.1016/j.bmcl.2006.01.090. Epub 2006 Feb 17. Bioorg Med Chem Lett. 2006. PMID: 16483773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page